TTRX 股价走势图
TTRX 股票价格预测
Turn Therapeutics Inc
$4.76
4.61%
$0.2
收盘价：May 20, 16:00:00 GMT-4
$4.8
0.84%
$0.04
盘后：May 20, 20:00:00 GMT-4
返回
Turn Therapeutics Inc (TTRX) 股票价格预测
关键数据
前收盘价
$4.55
开盘价
$4.63
当日区间
$4.5 - $4.81
52周范围
$2.57 - $26.5
交易量
23.5K
平均成交量
26.5K
股息收益率
--
每股收益（TTM）
-0.10
市值
$142.9M
什么是 TTRX？
Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. The company is headquartered in Westlake Village, California. The company went IPO on 2025-10-08. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.
